September 14, 2011
Lucentis receives Health Canada approval to treat vision loss from DME
Posted by: admin : Category: Information
Cohera’s TissuGlu Surgical Adhesive receives CE Mark approvalZimmer receives clearance for pediatric use of Universal Clamp Spinal Fixation SystemViamet commences VT-1161 Phase 1 clinical study to treat fungal infectionsFirst Edition: September 14, 2011Celecoxib inhibits GSK3 enzyme in lung cancer cells << Cohera's TissuGlu Surgical Adhesive receives CE Mark approval
View the Original article
Related posts:
- DiscoveryBioMed receives NIDDK grant for Cystic Fibrosis Corrector Ligand Drug Discovery program
- Teen milk drinkers less likely to suffer from Type 2 diabetes
- UMA introduces new healthcare education and career resource center
- Novo Nordisk announces free diabetes educational e-book series
- Two Toddler Deaths After Receiving The H1N1 Swine Flu Vaccine In Canada
Leave a Reply
You must be logged in to post a comment.
